STOCK TITAN

TVTX (NASDAQ: TVTX) shareholder files Form 144 for new stock sale

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

TVTX shareholder Jula Inrig has filed a Form 144 to sell 1,779 shares of common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of 57299.10. The proposed sale is expected around 02/04/2026 on the NASDAQ, where 89,472,327 common shares are outstanding.

The shares to be sold were acquired as restricted stock from the issuer on 01/31/2026. In the past three months, Jula Inrig has already completed several sales of TVTX common stock, including 15,000 shares for gross proceeds of 630004.50 and other smaller transactions disclosed in the filing.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the TVTX Form 144 filing disclose about planned share sales?

The Form 144 filing discloses that shareholder Jula Inrig plans to sell 1,779 TVTX common shares with an aggregate market value of 57299.10. The planned sale will occur on the NASDAQ around 02/04/2026 through Morgan Stanley Smith Barney LLC.

How many TVTX shares did Jula Inrig sell in recent transactions?

Recent disclosed sales include 15,000 TVTX common shares on 12/24/2025 for 630004.50, 6,956 shares on 02/03/2026 for 223429.38, 445 shares on 01/06/2026, and 2,031 shares on 01/05/2026, all with stated gross proceeds.

When and how were the TVTX shares in the new Form 144 acquired?

The 1,779 TVTX common shares covered by the new Form 144 were acquired on 01/31/2026 as restricted stock from the issuer. The filing notes the nature of the acquisition as “Restricted Stock” and lists the issuer as the source of the securities.

What trading venue and broker are involved in the planned TVTX share sale?

The planned sale of 1,779 TVTX common shares is to be executed on the NASDAQ. The broker listed is Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004, as disclosed in the filing.

How many TVTX common shares are outstanding according to this filing?

The filing reports that 89,472,327 TVTX common shares are outstanding. This figure provides context for the relative size of the planned 1,779-share sale disclosed under Rule 144, but it is a baseline ownership number rather than an amount being sold.

Does the TVTX Form 144 mention any special payment terms for the shares acquired?

For the 1,779 TVTX restricted shares acquired on 01/31/2026, the Form 144 lists the nature of payment as “Not Applicable.” The form also explains that any non-cash or installment consideration would need to be described, but no such arrangements are indicated here.
Travere Therapeutics Inc

NASDAQ:TVTX

TVTX Rankings

TVTX Latest News

TVTX Latest SEC Filings

TVTX Stock Data

2.64B
82.79M
0.75%
117.25%
13.55%
Biotechnology
Pharmaceutical Preparations
Link
United States
SAN DIEGO